RxDoctor Payments Data

Lenwood Smith, MD

General Practice · Durham, NCNPI 1750348777

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $772 of the $965 with a category attached, or 79.9%. 14 manufacturers reported payments, led by GT Medical Technologies, Inc at 33.3% of the total. 2025 is the largest year on record at $445, 4.2 times the $105 reported in 2019.

$965in general payments, 2019–2025

Across 28 payments — averaging $34.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$322
  • Biogen$194
  • Livanova USA, Inc.$127
  • Baxter Healthcare$72
  • Medtronic$61
  • CTL Medical Corporation$40
  • plus $150 from 8 others
$74,984in ownership & investment interests, 2019–2025

Across 7 payments — averaging $10,712 each. An ownership or investment interest held by the physician or an immediate family member.

  • The North Carolina Mutual Wholesale Drug Company Inc$75K

What the payments were for

  • Food & beverage$77280%
  • Education$19420%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$965 in reported general payments places this provider in the 80th percentile of 2,924 general practice providers in North Carolina.

See all general practice providers in North Carolina

Medicare billing

Part B allowed, 2024
$15,936
Medicare patients
118
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$8,493
Mirtazapine18$282
Levothyroxine Sodium14$162
Potassium Chloride13$144
Metformin Hcl12$136

Paid to pharmacies, not to this prescriber.

Other general practice in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →